The Tasmanian salmon industry is seeking to grow production safely and sustainably in the next two decades, further increasing the tangible benefits to the Tasmanian community. Our aim, through the Tasmanian Global Salmon Symposium partnership, is to deliver this by being the most environmentally...
Before this project our knowledge of the effects of husbandry on Amoebic Gill Disease (AGD) was limited. This project allowed on-farm assessment of effects of husbandry procedures and stock characteristics on AGD severity. Furthermore, we investigated the potential to re-use fresh water for...
Before this project our knowledge of immune response in Amoebic Gill Disease (AGD) was fundamentally limited and more information was required to assess the potential for immunomodulators in the management of AGD.
We confirmed that injection of bacterial DNA motif (CpG oligonucleotides) six...
Amoebic Gill Disease (AGD) is the main health problem affecting salmon industry in Southern Tasmania. To improve management of fish with AGD on the farms, the industry needs better understanding of AGD epidemiology. This will provide a basis on which to develop strategies for new...
This Project was funded by the Fisheries Research & Development Corporation(FRDC) for the “Development of a Stock Protection System for Flexible Oceanic Pens Containing Finfish“. The Project has been developed in conjunction with the Tasmanian Salmonid Growers Association(TSGA) &...
Amoebic gill disease (AGD) remains the major disease associated with sea-cage culture of Atlantic salmon in Tasmania. AGD is associated with a Paramoeba species infecting the gills. Current treatment involves multiple freshwater bathes for all fish. This treatment has a significant financial impact...